Nu Skin Enterprises Announces $400 Million Increase In Stock Repurchase Authorization

   Nu Skin Enterprises Announces $400 Million Increase In Stock Repurchase
                                Authorization

PR Newswire

PROVO, Utah, Aug. 1, 2013

PROVO, Utah, Aug. 1, 2013 /PRNewswire/ --Nu Skin Enterprises, Inc. (NYSE:
NUS) today announced that its board of directors has authorized a $400 million
extension to the company's existing stock repurchase authorization.

"As we build on another record quarter and ramp up for the global roll out of
our ageLOC TR90 weight management system, we are increasingly optimistic about
the future of our business," said Ritch Wood, chief financial officer. "We are
confident in the company's ability to continue to generate strong cash flow
and plan to use our financial strength to repurchase shares to create
shareholder value."

The board last increased the stock repurchase authorization by $250 million in
May 2012.

About Nu Skin Enterprises, Inc.
Nu Skin Enterprises, Inc. demonstrates its tradition of innovation through its
comprehensive anti-aging product portfolio, independent business opportunity
and corporate social responsibility initiatives. The company's scientific
leadership in both skin care and nutrition has established Nu Skin as a
premier anti-aging company. The company's anti-aging products feature the new
ageLOC^® suite of products including the ageLOC^® R^2 nutritional supplement,
ageLOC^® Galvanic Spa System and ageLOC^® Galvanic Body Spa™, as well as the
ageLOC^® Transformation daily skin care system. A global direct selling
company, Nu Skin operates in 53 markets worldwide and is traded on the New
York Stock Exchange under the symbol "NUS." More information is available at
http://www.nuskin.com.

Please Note: This press release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended that represent the
company's current expectations and beliefs. All statements other than
statements of historical fact are "forward-looking statements" for purposes of
federal and state securities laws and include, but are not limited to,
statements of management's expectations and beliefs regarding the company's
performance, new product introductions and stock repurchases; statements of
projections regarding cash flow and other financial items; statements of
belief; and statements of assumptions underlying any of the foregoing. In some
cases, you can identify these statements by forward-looking words such as
"believe," "expect," "project," "anticipate," "estimate," "intend," "plan,"
"targets," "likely," "will," "would," "could," "may," "might," the negative of
these words and other similar words.

The forward-looking statements and related assumptions involve risks and
uncertainties that could cause actual results and outcomes to differ
materially from any forward-looking statements or views expressed herein.
These risks and uncertainties include, but are not limited to, the following:

  othe company will determine the amount and timing of any stock repurchases
    by the company under the stock repurchase authorization based on multiple
    factors, including the company's net earnings, financial condition, cash
    requirements, future prospects, legal requirements or other factors deemed
    relevant by the company;
  oany failure of current or planned initiatives or products to generate
    interest among distributors and customers and generate sponsoring and
    selling activities on a sustained basis;
  orisks related to accurately predicting, delivering or maintaining
    sufficient quantities of products to support our planned initiatives or
    launch strategies, including possible ingredient supply limitations;
  ochallenging economic conditions globally;
  orisk of foreign currency fluctuations and the currency translation impact
    on the company's business associated with these fluctuations;
  orisks associated with general inquiries and complaints to consumer
    protection agencies in Japan regarding the activities of some
    distributors;
  orisks associated with our ability to manage rapid growth, particularly in
    our greater China region;
  oregulatory risks associated with the company's products, which could
    require the company to modify its claims or inhibit the company's ability
    to import or continue selling a product in a market if it is determined to
    be a medical device or if it is unable to register the product in a timely
    manner under applicable regulatory requirements;
  ocontinued regulatory scrutiny and investigations in Mainland China, which
    have from time to time in the past, and could in the future, negatively
    impact the company's business, including the interruption of sales
    activities in stores, loss of licenses, and the imposition of fines;
  oadverse publicity related to the company's business, products, industry or
    any legal actions or complaints by distributors or others;
  oany prospective or retrospective increases in duties on the company's
    products imported into the company's markets outside of the United States
    and any adverse results of tax audits or unfavorable changes to tax laws
    in the company's various markets; and
  ocontinued competitive pressures in the company's markets.

The company's financial performance and the forward-looking statements
contained herein are further qualified by a detailed discussion of associated
risks set forth in the documents filed by the company with the Securities and
Exchange Commission. The forward-looking statements set forth the company's
beliefs as of the date that such information was first provided and the
company assumes no duty to update the forward-looking statements contained in
this release to reflect any change except as required by law.

SOURCE Nu Skin Enterprises, Inc.

Website: http://www.nuskin.com
Contact: Investors, Scott Pond, +1-801-345-2657, spond@nuskin.com, or Media,
Kara Schneck, +1-801-345-2116, kschneck@nuskin.com
 
Press spacebar to pause and continue. Press esc to stop.